Lovaza 1 GM Oral Capsule
RxNorm 607044
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 607044 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Lovaza 1 GM Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Lovaza 1 GM Oral Capsule
(Atom ID: 6365085)
SYPrescribable
Synonym (SY):
Lovaza 1000 mg (at least 900 mg) Oral Capsule
(Atom ID: 8701048)
SYPrescribable
Synonym (SY):
Omacor 1 GM Oral Capsule
(Atom ID: 3621312)
SBDPrescribable
Semantic Branded Drug (SBD):
Omega-3 acid ethyl esters (USP) 1000 mg Oral Capsule [Lovaza]
(Atom ID: 12365090)
Patient Education
Omega-3 Fatty Acids
Omega-3 fatty acids are used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of triglycerides (a fat-like substance) in the blood in people with very high triglycerides. Omega-3 fatty acids are in a class of medications called antilipemic or lipid-regulating agents. Omega-3 fatty acids may work by decreasing the amount of triglycerides and other fats made in the liver.
[Learn More]
* Please review the disclaimer below.